SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Tularik Inc. (TLRK)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (401)1/29/2003 2:43:12 PM
From: Czechsinthemail   of 598
 
Actually, we may hear some interesting things from TLRK, but it is likely to be news related to partnerships and financing deals, new IND candidates and perhaps more on the patent front (if Rick continues his searches) rather than clinical results. My guess is that they might want to find partnerships for T67 and perhaps the antibody side of the oncogene program, saving the P1 candidates for later.

I would agree that the shareholders are at a disadvantage given TLRK's predilections toward stealth. If they are shopping for partnerships or financing, they will have to disclose information. This leaves shareholders the last to know.

On the plus side, the stock is now priced like a LEAP, so you can play the considerable upside potential of their program at low cost.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News